FirstRanker Logo

FirstRanker.com - FirstRanker's Choice is a hub of Question Papers & Study Materials for B-Tech, B.E, M-Tech, MCA, M.Sc, MBBS, BDS, MBA, B.Sc, Degree, B.Sc Nursing, B-Pharmacy, D-Pharmacy, MD, Medical, Dental, Engineering students. All services of FirstRanker.com are FREE

📱

Get the MBBS Question Bank Android App

Access previous years' papers, solved question papers, notes, and more on the go!

Install From Play Store

Download OU M.Pharma Pharmaceutics 1st Sem 2019 13306PCI Regulatory Affairs Question Paper

Download OU (Osmania University) M.Pharma-Pharmaceutics (Master of Pharmacy) 1st Sem 2019 13306PCI Regulatory Affairs Previous Question Paper

This post was last modified on 19 July 2020

OU M.Pharm Question Papers Last 10 Years 2010-2020 || Osmania University


FirstRanker.com
Firstranker's choice
Code. No: 13306/PCl

--- Content provided by⁠ FirstRanker.com ---

FACULTY OF PHARMACY
M. Pharmacy (Pharmaceutics ) I-Semester (Suppl.) Examination,
August 2019
Subject : Regulatory Affairs
Time: 3 Hrs Max. Marks: 75

--- Content provided by​ FirstRanker.com ---

Note: Answer any Five Questions. All Questions Carry Equal Marks.

  1. (a) Write a note on importance and types of Drug Master file 7
    (b) Explain the contents of Hatch-Waxman Act 5
    (c) Write abt the importance of Post marking surveillance 3
  2. Explain the regulatory requirements for ANDA approval process in US 15
  3. --- Content provided by​ FirstRanker.com ---

  4. (a) Describe the importance, preparation and organization of CTD 10
    (b) Describe the objectives and structure of Harmonization guidelines (ICH) 5
  5. Explain in brief
    1. The regulations for medical devices 8
    2. Regulatory requirements of MHRA 7
  6. --- Content provided by FirstRanker.com ---

  7. Give a brief note on each part of the contents of Investigational New Drug Application (IND) 15
  8. (a) What is Investigational Medicinal Product dossier (IMPD)? Explain the requirements and contents of IMPD. 7
    (b) Write a note on Scale up process 8
  9. Explain briefly varis phases of clinical trials and design of clinical trials for the submission of data to FDA for getting NDA approval. 15
  10. Give a brief note on the following:
    1. Institutional Review Board (IRB) 8
    2. --- Content provided by FirstRanker.com ---

    3. Informed Consent 7


--- Content provided by⁠ FirstRanker.com ---

This download link is referred from the post: OU M.Pharm Question Papers Last 10 Years 2010-2020 || Osmania University